Utility of preoperative outcomes of nutritional evaluation in patients with newly diagnosed ovarian cancer Authors: Shilpa Mokshagundam, Summer S Bethurum, Katherine A Kleinberg, Margaret R Mahoney, Alaina J Brown, Lauren S Prescott Published: 2026 ABSTRACT AbstractBackgroundMalnutrition is associated with adverse surgical and oncologic outcomes. This work aims to evaluate the prevalence of malnutrition and vitamin deficiency, as well as completion of preoperative evaluation of nutritional status, in patients with ovarian cancer.MethodsA retrospective single-institution cohort study of patients undergoing surgery for newly diagnosed ovarian cancer between January 1, 2018 and July 1, 2024 was performed. Malnutrition was defined as: albumin ≤3.0 g/dL, prealbumin ≤18 mg/dL or Malnutrition Screening Tool (MST) ≥2. Vitamin deficiencies and insufficiencies were defined in accordance with our high-risk surgical encounter clinic guidelines. Evaluation of nutrition status was defined as the documentation of MST, albumin, prealbumin or vitamin levels within 90 days of surgery.Results235 patients met inclusion criteria, with median age 61 and body mass index 27 kg/m2. Most patients had advanced stage disease (145,61.7%). All patients had documentation of the MST, and 219 (93.2%) had any nutritional lab evaluation, with albumin assessment being most common (196, 83.4%). Of the 235 patients, 114 (48.5%) met criteria for malnutrition. Among the fewer patients who underwent vitamin deficiency workup (140, 60.0%), vitamin C and D abnormalities were found in 12/100 (12.0%) and 34/105 (32.4%) patients, respectively. Vitamin C and D insufficiencies were found in 48/100 (48.0%) and 72/105 (68.6%). Vitamin B12 and folate deficiencies occurred in 24/124 (19.4%) and 11/119 (9.3%) patients, respectively.ConclusionMalnutrition and vitamin abnormalities are common among patients with ovarian cancer. Comprehensive and standardized preoperative evaluation of nutritional status and vitamin deficiency is recommended.Keywords: Ovarian cancer, Malnutrition, Vitamin deficiency, Preoperative optimization, Neoadjuvant chemotherapy Introduction Malnutrition is common among cancer patients and is associated with increased morbidity and mortality (Bossi et al., 2022; Muscaritoli et al., 2017). Malnutrition is defined as a deficit between energy intake and expenditure (Bossi et al., 2022; Muscaritoli et al., 2017; Arends, 2024). The etiology of malnutrition in cancer patients is multifactorial, including increased metabolic demand due to tumor growth and associated immune response, decreased appetite, physical barriers to eating, and pre-existing dietary habits (Chiu et al., 2024; Kadakia et al., 2022). Although there is a paucity of contemporary studies evaluating malnutrition in gynecologic cancer, available data estimates that malnutrition affects approximately 11–45% of patients with gynecologic cancers (Kadakia et al., 2022; Laky et al., 2007; Goins et al., 2022; Hébuterne et al., 2014). Malnutrition has been associated with adverse surgical and oncologic outcomes. Malnourished patients have a three times higher risk of perioperative complication and a five times increased risk of surgical morbidity (Wischmeyer et al., 2018). Among patients with gynecologic cancers, adverse surgical outcomes include increased rates of readmission, reoperation, blood transfusion, infection, and intensive care unit admissions (Goins et al., 2022; Kathiresan et al., 2011). Additionally, malnutrition is associated with adverse oncologic outcomes, including chemotherapy-induced toxicity and decreased overall survival (Gregg et al., 2011; Liu et al., 2016). Vitamin deficiencies can also negatively impact cancer patients. Vitamin D deficiency is common among critically ill oncology patients and is an independent risk factor for hospital and one-year mortality (Buchtele et al., 2020). Likewise, vitamin C deficiency is common in patients with advanced cancer and associated with poor oncologic outcomes (Mayland et al., 2005). Patients with ovarian cancer are at particularly high risk for malnutrition, as they are more likely to be diagnosed with advanced stage disease with ascites, abdominal pain and decreased appetite. These symptoms often lead to changes in dietary patterns and subsequently compromised nutrition (Kadakia et al., 2022). Many ovarian cancer patients ultimately undergo surgery as a part of the management of their disease. Accordingly, an emphasis on nutritional status during preoperative assessment and optimization is important as per the recommendations of many clinical societies, including the American College of Surgeons, the American Society for Enhanced Recovery, and the Perioperative Quality Initiative Workgroup (Wischmeyer et al., 2018; Surgeons TACo, 2016). In 2017 the National Comprehensive Cancer Network (NCCN) began recommending formal evaluation of nutritional status in newly diagnosed ovarian cancer patients, which can include assessment of body mass index (BMI), serum albumin, and qualitative metrics such as the prognostic nutrition index (PNI) (NCCN, 2025). Despite these recommendations, little is known about rate of evaluation of nutrition status or prevalence of vitamin deficiencies in ovarian cancer populations. Our objectives were to determine the prevalence of preoperative malnutrition and vitamin deficiencies, as well as to assess compliance with NCCN guidelines for the evaluation of nutritional status in patients newly diagnosed with ovarian cancer. Methods Study design and data abstraction This study was approved by our local Institutional Review Board. This was a retrospective cohort study evaluating all patients who underwent surgery for ovarian cancer at a tertiary care center within an urban city in the southeastern United States from January 2018 through July 2024. Patients were included if they had a new histologic diagnosis of ovarian cancer and underwent surgery at our institution. Patients with dual primary malignancies, borderline tumors of the ovary, disease recurrence, or aborted surgeries were excluded. Patients were identified from a pre-existing surgical REDCap™ database which was established on January 1, 2018. This secure, deidentified database was established within our department to track peri- and postoperative outcomes for patients undergoing surgery. Demographic and surgical data, including age, BMI, race, ethnicity, marital status, insurance, date of surgery, estimated blood loss (EBL), and specified laboratory values (albumin, prealbumin, vitamins B12, C, D, folate and zinc) were collected via automatic data abstraction from our electronic medical record (EMR) and stored in REDCap™. After data review, zinc was removed as a secondary outcome as only five patients had zinc levels drawn, none of whom met criteria for deficiency. Manual chart review was then conducted to abstract disease stage, surgical approach, and procedure. The Malnutrition Screening Tool (MST) was completed by preoperative nursing via an EMR questionnaire on the day of surgery, as per institution protocol. The MST is a validated, two-question survey that inquires on weight loss and appetite, providing a score to identify patients at high risk for malnutrition. This screening tool is depicted in Fig. 1. (Ferguson et al., 1999) Data validation was performed by two reviewers. Malnutrition Screening Tool (MST) and Scoring. Clinical definitions The aforementioned labs obtained within 90 days prior to surgery were analyzed. Malnutrition was defined by either albumin ≤3.0 g/dL, prealbumin ≤18 mg/dL, or MST score ≥ 2. Definition of vitamin deficiencies and insufficiencies were adapted from our institution's high-risk surgical encounter clinic (HI-RISE) guidelines and institution's laboratory parameters (Fig. 2). Vitamin deficiencies were thus defined as B12 ≤ 300 pg/mL, vitamin C < 11 mol/L, vitamin D < 25 ng/mL, folate <6 ng/mL, and zinc <9 mol/L. Vitamin insufficiencies were defined for vitamin C and vitamin D as vitamin C ≤ 30 umol/L and vitamin D ≤ 40 ng/mL (Colacci et al., 2020; Zhang et al., 2018; Léger, 2008; Gao et al., 2019; Iglar and Hogan, 2015; Weimann et al., 2017). Compliance with NCCN guidelines to evaluate nutritional status in newly diagnosed ovarian cancer patients was defined by receipt of any nutritional evaluation within 90 days prior to surgery. Institutional Algorithms for Workup and Management of Anemia, Vitamin C and Vitamin D Deficiency. Statistical analysis Wilcoxon rank-sum test was utilized to compare medians between patients with malnutrition and the entire patient cohort with continuous variables. Fisher's exact test was employed to assess for association between categorical groups. All data was analyzed using Stata/BE 18.0 (StataCorp). In all analyses, p-value <0.05 was interpreted as statistically significant. Results A total of 235 patients met inclusion criteria for this study. Demographic and clinical characteristics for patients with malnutrition versus those who did not meet criteria for malnutrition are depicted in Table 1. Most patients were White (90.2%), non-Hispanic (95.7%), married (64.7%) with a median age of 61 years and BMI of 27 kg/m2. Insurance coverage for the cohort was divided almost equally between private and public coverage (49.4% and 46.8% respectively). Most patients had advanced stage III/IV disease (61.7%). One hundred and forty-four patients underwent debulking surgery; of these patients, 44 (30.6%) underwent a primary debulking procedure and 100 (69.4%) underwent interval debulking procedure. When comparing demographic and clinical characteristics between patients with malnutrition and the entire cohort, a greater proportion of patients with malnutrition had state or federal health insurance (p = 0.02). Table 1Demographics and Clinical Characteristics.CharacteristicAll PatientsPatients with MalnutritionaPatients Not Meeting Criteria for MalnutritionP-ValuePatients, N235114121Ageb, median (IQR), years61 (50–68)62 (50–71)60 (49–68)0.37BMI, median (IQR), kg/m227 (23−32)27 (23–32)28 (23−33)0.31Race, N (%)0.09White212 (90.2)103 (90.4)109 (90.1)Black14 (6.0)5 (4.4)9 (7.4)Asian7 (3.0)4 (3.5)3 (2.5)American Indian2 (0.8)2 (1.8)0 (0.0)Ethnicity, N (%)0.10Hispanic10 (4.3)2 (1.8)8 (6.6)Non-Hispanic225 (95.7)112 (98.2)113 (93.4)Marital Status, N (%)0.55Single49 (20.9)24 (21.1)25 (20.7)Married152 (64.7)70 (61.4)82 (67.8)Divorced20 (8.5)11 (9.6)9 (7.4)Widowed14 (6.0)9 (7.9)5 (4.1)Insurance, N (%)0.02Private116 (49.4)46 (40.4)64 (52.9)Public110 (46.8)66 (57.9)50 (41.3)Other/None9 (3.8)2 (1.8)7 (5.8)Cancer Stage, N (%)0.28I65 (27.7)33 (29.0)32 (26.4)II25 (10.6)15 (13.2)10 (8.3)III90 (38.3)37 (32.5)53 (43.8)IV55 (23.4)29 (25.4)26 (21.5)Neoadjuvant Chemotherapy, N (%)0.51Yes100 (42.6)46 (40.4)54 (44.6)No135 (57.4)68 (59.6)67 (55.4)Debulking Surgeryc, N14469750.59Primary Debulking, N (%)44 (30.6)23 (33.3)21 (28.0)Interval Debulking, N (%)100 (69.4)46 (66.7)54 (72.0)Abbreviations: IQR, interquartile range; BMI, body mass index.aMalnutrition is defined as albumin ≤3, pre-albumin ≤18, or MST ≥2.bAge is defined as the age at time of surgery.cThe denominator used to calculate percentage of primary and interval debulking is based on patients who underwent debulking surgery, not the entire cohort (N = 144 69, 75 respectively). Demographics and Clinical Characteristics. Abbreviations: IQR, interquartile range; BMI, body mass index. Malnutrition is defined as albumin ≤3, pre-albumin ≤18, or MST ≥2. Age is defined as the age at time of surgery. The denominator used to calculate percentage of primary and interval debulking is based on patients who underwent debulking surgery, not the entire cohort (N = 144 69, 75 respectively). Malnutrition was defined as the presence of one of the following: albumin ≤3.0 g/dL, prealbumin ≤18 mg/dL, or MST score ≥ 2. One hundred and fourteen patients (48.5%) met criteria for malnutrition by this criteria. Of the 235 patients included in our study, the majority of patients (219, 93.2%) had a laboratory evaluation including albumin or prealbumin within 90 days of surgery (Table 2). Most of these patients had albumin evaluated (196, 83.4%), while prealbumin was assessed in a minority of these patients (87, 37.0%). All patients underwent nutrition assessment using the MST. Seventy-one patients (30.2%) were identified as high risk for malnutrition by MST ≥ 2. Remarkably fewer patients underwent evaluation for vitamin deficiencies (140, 59.6%) as shown in Table 2. The most common vitamin assessed was vitamin B12 (124, 52.8%), followed by folate (119, 50.6%), vitamin D (105, 44.7%) and vitamin C (100, 42.6%). Vitamin B12 deficiency was recognized in 24 (10.2%) patients. When quantified among patients of whom vitamin B12 was assessed, the adjusted prevalence increased to 19.4%. Folate deficiency was noted in 11 (4.7%) patients, with a 9.3% adjusted prevalence among those assessed. Vitamin C deficiency and insufficiency were found in 12 (5.1%) and 48 (20.4%) of all patients, with an adjusted prevalence of 12.0% and 48.0%, respectively. Vitamin D deficiency and insufficiency were identified in 34 (14.7%(and 72 (30.6%) of all patients, with an adjusted prevalence of 32.4% and 68.6% respectively. Table 2Prevalence of Malnutrition and Vitamin Abnormalities.CharacteristicAll PatientsPatients with Specified EvaluationaPatients, N235Any laboratory nutritional evaluation, N (%)219 (93.2)n/aMalnutritionb, N (%)114 (48.5)n/aAlbumin31 (13.2)31 / 196 (15.8)Prealbumin41 (17.4)41 / 87 (47.1)MST71 (30.2)n/aVitamin Deficiency/Insufficiencyc, N (%)Vitamin B12 Deficiency24 (10.2)24 / 124 (19.4)Folate Deficiency11 (4.7)11 / 119 (9.3)Vitamin C Deficiency12 (5.1)12 / 100 (12.0)Vitamin C Insufficiency48 (20.4)48 / 100(48.0)Vitamin D Deficiency34 (14.7)34 / 105 (32.4)Vitamin D Insufficiency72 (30.6)72 / 105 (68.6)aThe denominator varies for all of the specific laboratory assessments. The number of patients who had lab assessment for each of the aforementioned variables is as follows: albumin = 196, prealbumin = 87, vitamin B12 = 124, folate = 119, vitamin C = 100, vitamin D = 105.bMalnutrition is defined as albumin ≤3, pre-albumin ≤18, or MST ≥ 2.cVitamin deficiencies are defined as: vitamin B12 ≤ 300 pg/mL, vitamin C < 11 umol/L, vitamin D < 25 ng/mL, folate <6 ng/mL, and zinc <9 mol/L. Vitamin insufficiencies are evaluated for vitamin C and vitamin D and defined as: vitamin C ≤ 30 umol/L and vitamin D ≤ 40 ng/mL. Prevalence of Malnutrition and Vitamin Abnormalities. The denominator varies for all of the specific laboratory assessments. The number of patients who had lab assessment for each of the aforementioned variables is as follows: albumin = 196, prealbumin = 87, vitamin B12 = 124, folate = 119, vitamin C = 100, vitamin D = 105. Malnutrition is defined as albumin ≤3, pre-albumin ≤18, or MST ≥ 2. Vitamin deficiencies are defined as: vitamin B12 ≤ 300 pg/mL, vitamin C < 11 umol/L, vitamin D < 25 ng/mL, folate <6 ng/mL, and zinc <9 mol/L. Vitamin insufficiencies are evaluated for vitamin C and vitamin D and defined as: vitamin C ≤ 30 umol/L and vitamin D ≤ 40 ng/mL. Of the 235 patients included in our study, all patients had a nutrition assessment using the MST, therefore meeting compliance with NCCN guidelines. The majority of these patients (196, 83.4%) also had some form of labs completed to evaluate nutritional status and vitamin deficiencies prior to surgery (Table 3). Of these patients, 192 (81.7%) patients had albumin evaluated, and 66 (28.1%) patients had prealbumin assessed. The number of patients who received vitamin level evaluation among those with preoperative labs is as follows: vitamin B12 (82, 24.9%), folate (78, 33.2%), vitamin C (77, 32.8%) and vitamin D (90, 38.3%). Table 3Compliance with NCCN Guidelines for Evaluation of Nutritional Status and Vitamin Levels Prior to Surgery.CharacteristicAll PatientsPatients, N235Preoperative Labs Completed, N (%)196 (83.4)NutritionAlbumin192 (81.7)Prealbumin66 (28.1)MST235 (100)VitaminsVitamin B1282 (24.9)Folate78 (33.2)Vitamin C77 (32.8)Vitamin D90 (38.3) Compliance with NCCN Guidelines for Evaluation of Nutritional Status and Vitamin Levels Prior to Surgery. Discussion The primary objective of this study was to understand practice patterns in preoperative workup of malnutrition and vitamin deficiencies relative to NCCN guidelines, as well as the prevalence of malnutrition and vitamin deficiency in patients with newly diagnosed advanced ovarian cancer. The majority of our cohort (69.4%) underwent an interval cytoreductive surgery, which is reflective of national trends towards neoadjuvant chemotherapy in advanced ovarian cancer (Lamiman et al., 2025). Thus, this study presents data primarily from patients actively receiving chemotherapy in preparation for surgery. This period of time represents a potential “window of opportunity” for optimization of nutrition status, in order to achieve an optimal surgical and oncologic outcome. The majority of patients underwent some form of laboratory nutrition assessment, leading to overall high compliance with NCCN guidelines. However this workup was frequently limited to measurement of serum albumin alone. Importantly, while only a proportion of patients underwent evaluation for vitamin levels, among those who were tested for vitamin C and D abnormalities, approximately half had insufficiency in at least one of these critical vitamins. Vitamin C is an essential nutrient playing a key role in immune function, wound healing, iron absorption and anti-thrombosis among others (Bedhiafi et al., 2022; Abdullah et al., 2023). Vitamin C deficiency is common in resource-poor countries and historically, has been conjectured to be rare in resource rich countries (Carr and Rowe, 2020). Ovarian cancer and chemotherapy can also mask symptoms of severe vitamin C deficiency, including lethargy, weight loss, anorexia, and anemia associated with easy bleeding (Carr and Rowe, 2020). Our data suggests that ovarian cancer patients may be at higher risk for vitamin C deficiency, with 5.1% of our cohort meeting criteria for vitamin C deficiency. Importantly, vitamin C deficiency has been identified as a prognostic factor for overall survival in patients with stage IV ovarian cancer (HR 1.45, p = 0.030) (Zhu et al., 2025). Data also suggests a positive relationship between vitamin C supplementation and overall survival in advanced ovarian cancer, though further studies are needed (Sun et al., 2023). Vitamin C replacement is a low cost and potentially highly impactful intervention that should be considered in this population. Conversely, vitamin D deficiency is very common and is problematic in both resource poor and rich countries, attributed to inadequate sun exposure and intake (Nair and Maseeh, 2012). As with vitamin C deficiency, vitamin D deficiency is associated with poor surgical outcomes and mortality (Gao et al., 2019; Zhang et al., 2019). The VITamin D and OmegA-3 TriaL (VITAL) trial demonstrated that vitamin D supplementation reduced cancer progression and increased survival time in a composite of all cancer types, including gynecologic cancers (Manson et al., 2020). In our study, only 38.3% of patients underwent preoperative workup for vitamin D deficiency. However, of the patients with vitamin deficiencies, vitamin D was the most common. Given the low rates of evaluation, the true prevalence of vitamin deficiencies in our population might be underestimated. Consequently, we might be missing an opportunity to detect and treat easily reversible vitamin deficiencies. Strengths of this study include a large number of ovarian cancer cases over a 6-year period, as well as the use of objective markers for nutritional status. Few studies have assessed compliance with NCCN guidelines, and to our knowledge, this is the first study to assess compliance with NCCN recommendations for nutritional status assessment of patients with ovarian cancer. However, nutritional assessments were not conducted in a comprehensive and standardized fashion, which obscures a more accurate understanding of the prevalence of malnutrition or vitamin deficiencies. Our study was limited to data that was abstracted from our EMR. Given that our institution is a tertiary care center with a large catchment area, patients may have had preoperative testing elsewhere with results that were not easily extractable from our EMR. Therefore, we may be underestimating the number of patients who underwent a comprehensive preoperative evaluation. Additionally, we utilized a more restrictive cut off for evaluation of vitamin C and D deficiencies, which may underestimate the prevalence of vitamin C and D deficiencies. Insufficiencies were also analyzed as a measurement of the upper limit of abnormal. Prevalence of abnormal vitamin C and D levels when comparing deficiency (lower cut-off) and insufficiency (higher cut-off) doubled. Therefore, using a more restrictive threshold might not capture all patients who have effectual physiologic changes due to low vitamin C and D stores. Our findings are hypothesis generating, and future research evaluating the prevalence of vitamin deficiencies in more diverse populations and in other gynecologic cancers is warranted. Additional limitations include lack of consensus on the optimal evaluation of nutritional status. Previous studies have demonstrated a wide range in prevalence of malnutrition, likely accounting for variation in evaluation methods utilized. We defined malnutrition as albumin ≤3.0 g/dL based on a consensus statement on preoperative nutrition screening by the American Society for Enhanced Recovery and Perioperative Quality Initiative. However, some studies have defined malnutrition as albumin ≤3.5 g/dL (Goins et al., 2022). Our lower threshold might have falsely underestimated the prevalence of malnutrition in this patient population. Both albumin and prealbumin are utilized as serum markers to identify malnutrition, but both are acute phase reactants and can be impacted by cancer, chemotherapy, and inflammation. Given limitations in these laboratory assessments, some experts endorse the use of qualitative assessments. There are several options for nutritional risk screening tools which are simple, efficient tools to detect at-risk patients. As noted previously, our institution uses the MST which is integrated into our EMR and implemented systematically at the time of preoperative admission. Recognition and treatment of malnutrition and vitamin deficiencies is an inexpensive and simple mechanism for optimizing surgical and oncologic outcomes (Iglar and Hogan, 2015; Weimann et al., 2017). Our study is one of the first to call attention to this critical opportunity. This study adds to the limited literature on malnutrition in oncology patients by demonstrating the relatively high prevalence of malnutrition and vitamin deficiencies in our cohort. Additionally, this highlights the potential for relatively simple interventions, such as pre-operative nutritional supplementation, to positively impact surgical and oncologic outcomes. This practice of preoperative malnutrition and vitamin deficiency workup could be expanded outside of gynecologic oncology to more broadly include all cancer patients. However, further research is needed on the utility and cost of such clinical practices. Conclusions Optimizing preoperative nutritional status and vitamin levels is an opportunity to increase the safety and patient-centered focus of surgical care for oncology patients. Our data demonstrate that there are opportunities for improvement in the preoperative evaluation and management of malnutrition and vitamin deficiencies among patients with gynecologic cancer. Early evaluation and proper counseling along with vitamin supplementation have the potential to greatly improve patient outcomes. Future development of institutional protocols for assessment of nutritional status and prompt initiation of supplementation should be further explored. CRediT authorship contribution statement Shilpa Mokshagundam: Writing – review & editing, Writing – original draft, Data curation, Conceptualization. Summer S. Bethurum: Writing – review & editing, Writing – original draft, Formal analysis, Data curation. Katherine A. Kleinberg: Writing – review & editing, Writing – original draft, Formal analysis, Data curation. Margaret R. Mahoney: Writing – review & editing, Data curation. Alaina J. Brown: Writing – review & editing, Writing – original draft, Conceptualization. Lauren S. Prescott: Writing – review & editing, Writing – original draft, Supervision, Project administration, Formal analysis, Data curation, Conceptualization. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References